Natalizumab-induced POU2AF1/Spi-B upregulation-Reference-Cited by-同舟云学术

Natalizumab-induced POU2AF1/Spi-B upregulation

Published:2016-03-31 Issue:3 Volume:3 Page:e223
ISSN:2332-7812
Container-title:Neurology - Neuroimmunology Neuroinflammation
language:en
Short-container-title:Neurol Neuroimmunol Neuroinflamm

Author:

Meira Maria,Sievers Claudia,Hoffmann Francine,Haghikia Aiden,Rasenack Maria,Décard Bernhard F.,Kuhle Jens,Derfuss Tobias,Kappos Ludwig,Lindberg Raija L.P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Clinical Neurology,Neurology

Reference40 articles.

1. Multiple sclerosis

2. Clinical effects of natalizumab on multiple sclerosis appear early in treatment course

3. Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS

4. Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of B-cell activating factor gene variants with serum anti-JCV antibody positivity in male patients with multiple sclerosis under natalizumab treatment: Implications for progressive multifocal leukoencephalopathy risk stratification;Journal of the Neurological Sciences;2024-06

2. Integrative Data Analysis to Uncover Transcription Factors Involved in Gene Dysregulation of Nine Autoimmune and Inflammatory Diseases;2024-04-28

3. Progressive Multifocal Leukoencephalopathy;Neurology;2023-10-17

4. Rates of John Cunningham virus seroconversion greatly reduced in natalizumab‐treated patients during COVID‐19‐related lockdowns;European Journal of Neurology;2023-09-14

5. Identification of Signature Genes in the PD-1 Relative Gastric Cancer Using a Combined Analysis of Gene Expression and Methylation Data;Journal of Oncology;2022-12-15